Imac Holdings Inc's Competitiveness
A competitive positioning analysis and financial ratio benchmarking of Imac Holdings Inc (BACK) against its publicly traded competitors: sales growth, net income, profitability, valuation and market share, plus each peer's market capitalization, revenue, income and employees. Free below: the top 5 peers. Subscriber access adds the full competitor list and CSV downloads.
Key Findings: Imac Holdings Inc vs Its Competitors
- TTM: Trailing 12-month revenue of 15M vs 176,549M combined for tracked competitors (0.0% combined share).
- Trending: Latest-quarter revenue run-rate is decelerating (-99.4% annualized vs trailing 12 months), vs holding steady (+0.0%) for its tracked peer group.
- Growth: Imac Holdings Inc generated -62.3% revenue growth year over year in Q3 2025, vs 7.1% for its tracked competitors combined.
- Profitability: Its -14,505.6% net margin compares with 8.7% for the peer group.
- Scale: Imac Holdings Inc ranks #48 of 51 companies by market capitalization in the Healthcare Facilities industry, holding 0.0% of industry market cap.
- Peer revenue share: Imac Holdings Inc accounted for 0.0% of combined revenue among its tracked peer group, up from 0.0% a year earlier.
- Peer differentiation: Revenue per employee of $0.05M compares with $0.20M for the peer group (0.3x).
Every figure above is sourced and cited in detail further down this page (Market Structure, Profitability & Cost Structure, Productivity vs Peers).
BACK Sales vs. its Competitors, Q3 2025
Imac Holdings Inc reported revenue contraction of 62.30 % year on year in Q3 2025, below its competitors' combined revenue growth of 7.14 %.
With a net margin of -14,505.64 %, Imac Holdings Inc reported lower profitability than its competitors (8.65 %).
Imac Holdings Inc generated 0.00 % of the combined sales of its peer group, up from 0.00 % a year earlier.
Imac Holdings Inc vs. its Competitors, Q3 2025
Revenue growth, year on year
Net margin
Revenue run-rate vs trailing 12 months
TTM net margin
TTM = trailing twelve months. Run-rate annualizes the latest quarter (×4) and compares it to TTM. In millions of $. High-Confidence Competitors are named as a competitor directly in an SEC filing; Similar-Size Competitors are the closest peers by market-cap rank within the same industry; Similar Growth & Profitability Competitors are the closest peers by combined revenue growth, operating margin and ROIC, all independent of the competitor list.
TTM revenue, latest-quarter run-rate and net income/margin benchmarked across Imac Holdings Inc and its 4 competitor groupings. Available under Commercial License.
| Entity | TTM Revenue | Rev Run-rate vs TTM |
|---|---|---|
| Imac Holdings Inc | $12,345M | +12.3% · Accelerating |
| Competitors combined | $12,345M | +12.3% · Accelerating |
| Similar-Size Competitors (3) | $12,345M | +12.3% · Accelerating |
TTM revenue, run-rate and net margin benchmarking across Imac Holdings Inc's competitor groups requires a Commercial License.
For context: the Healthcare Facilities industry grew revenue 14.7% year over year, combined, vs -62.3% for Imac Holdings Inc. Imac Holdings Inc's share of combined industry revenue moved from 0.00% to 0.00%, a gain of 0.00 percentage points.
Imac Holdings Inc's Competitor Quality Breadth
Share of each group, trailing 12 months: profitable (net margin > 0), expanding (revenue growth > 0), growing faster than the industry's own median, and financially distressed (Piotroski F-Score of 2 or below).
| Entity | Profitable | Expanding | Above Industry Growth | Distressed |
|---|---|---|---|---|
| Imac Holdings Inc | - | - | - | Yes |
| Competitors combined (16) | ||||
| Similar-Size Competitors (4) |
Source: CSIMarket API, trailing 12 months. Altman Z-Score is not shown here: it is not populated in the underlying data for any company. Percentages are of companies in each group that report the relevant metric, not of the full group size.
BACK Stock Performance relative to its Competitors
BACK Stock Performance relative to Similar-Size Competitors
5 Best-Performing Tracked Competitors, Trailing 12 Months
| # | Competitor | TTM Share Price Return | vs U.S.A. 500 |
|---|---|---|---|
| 1 | National Healthcare Corp | 282.9% | Outperformed |
| 2 | Aveanna Healthcare Holdings Inc | 282.9% | Outperformed |
| 3 | Viemed Healthcare Inc | 282.9% | Outperformed |
| 4 | Tenet Healthcare Corp | 282.9% | Outperformed |
| 5 | Healthcare Services Group Inc | 282.9% | Outperformed |
TTM share price return and U.S.A. 500 outperformance for Imac Holdings Inc's best-performing tracked competitors requires a Commercial License.
Source: CSIMarket API, trailing 12 months.
Publicly Traded Peers of Imac Holdings Inc
Revenue and income for trailing 12 months, in millions of $, except employees| Company | Market Cap | Revenues |
|---|---|---|
| Imac Holdings Inc | 0.00 | 15.22 |
| Hca Healthcare Inc | 97,600.88 | 76,388.00 |
| Tenet Healthcare Corp | 21,681.52 | 21,812.00 |
| Fresenius Medical Care Ag | 12,998.75 | 21,982.91 |
| Encompass Health Corporation | 12,272.50 | 6,206.10 |
| Universal Health Services Inc | 10,572.92 | 18,114.49 |
| SUBTOTAL | 175,566.52 | 178,970.96 |
Sign in to see all competitors of Imac Holdings Inc .
Sources: Imac Holdings Inc's official press releases and regulatory filings; CSIMarket.com's market research; and the financial filings and press releases of the other companies cited.
Updated on:
Focus of this report: publicly traded companies. Ten additional tables on Imac Holdings Inc versus competitors, including market share analysis, are in the navigation menu under Competition. To download the tables, please subscribe.
Imac Holdings Inc's Business Segment Mix vs Peers
Revenue by operating segment or division, as named and reported by each company. Segment names are the filer's own and are not standardized across companies. Do not assume a same-named or similarly-named segment is defined identically between two companies. Shares are of each company's own total revenue and are not required to sum to 100% (intersegment revenue, unallocated items).| Company | Largest Segment |
|---|---|
| Hca Healthcare Inc | American Group 34.90 % |
| Tenet Healthcare Corp | Hospital Operations 75.34 % |
| Encompass Health Corporation | Inpatient Rehabilitation 100.00 % |
| Universal Health Services Inc | Acute Care Hospital Services 56.27 % |
| National Healthcare Corp | Inpatient Services Segment 86.62 % |
Source: operating segment revenue as reported in each company's SEC filings (10-K/10-Q), via the CSIMarket API, leaf-level reportable segments only (parent roll-up segments are excluded where sub-segments are separately disclosed).
Imac Holdings Inc's Productivity vs Peers Comparison
Revenue and income per employee, trailing 12 months, in $; market cap in millions of $| Company | Market Cap | Revenue / Employee | Income / Employee |
|---|---|---|---|
| Imac Holdings Inc | 0 | 50,722 | -41,497 |
| Hca Healthcare Inc | 97,601 | 238,713 | 24,419 |
| Tenet Healthcare Corp | 21,682 | 220,323 | 32,061 |
| Fresenius Medical Care Ag | 12,999 | 200,395 | 12,163 |
| Encompass Health Corporation | 12,273 | 147,764 | 19,840 |
| Universal Health Services Inc | 10,573 | 178,468 | 15,273 |
| PEERS TOTAL | 175,567 | 201,887 | 16,975 |
Sign in to see all peers for Imac Holdings Inc .
Imac Holdings Inc's Position in Industry Market Structure
Market-capitalization share and concentration across all 48 companies in Imac Holdings Inc's industry classification, broader than the peer set above. Market cap in millions of $.Imac Holdings Inc ranks #48 of 48 companies by market capitalization in its industry, holding 0.00 % of total industry market cap. The industry's Herfindahl-Hirschman Index (HHI) is 1,726, indicating a moderately concentrated market structure (U.S. antitrust guidance: below 1,500 unconcentrated, 1,500 to 2,500 moderately concentrated, above 2,500 highly concentrated).
| Rank | Company | Market Cap | Industry Share |
|---|---|---|---|
| 1 | Hca Healthcare Inc | 97,601 | 38.51 % |
| 2 | Tenet Healthcare Corp | 21,682 | 8.55 % |
| 3 | Fresenius Medical Care Ag | 12,999 | 5.13 % |
| 4 | Brightspring Health Services Inc | 12,410 | 4.90 % |
| 5 | Encompass Health Corporation | 1,234 | 5.2% |
| 6 | Davita Inc | 1,234 | 5.2% |
| 7 | Universal Health Services Inc | 1,234 | 5.2% |
| 8 | Ensign Group Inc | 1,234 | 5.2% |
| 9 | Pacs Group Inc | 1,234 | 5.2% |
| 10 | Hims and Hers Health Inc | 1,234 | 5.2% |
| 48 | Imac Holdings Inc | 0 | 0.00 % |
Market cap and industry share for the rest of Imac Holdings Inc's industry peers requires a Commercial License.
Source: CSIMarket API (daily market-structure computation) across CSIMarket's industry classification, market capitalization as of 2026-09-28.
Imac Holdings Inc's Same-Size Peers & Stock Performance
Peers chosen by closeness in market-cap rank within the same industry classification (not the named-competitor list above). Trailing 12-month total return, 3-month price momentum, beta and Sharpe ratio vs the broad U.S. market.| Rank | Company | Market Cap | TTM Return |
|---|---|---|---|
| 43 | Basel Medical Group Ltd | 5 | - |
| 44 | Aesthetic Medical International Holdings Group Limited | 2 | - |
| 45 | Biorestorative Therapies Inc | 1,234 | 12.3% |
| 46 | Jrsis Health Care Corp | 1,234 | 12.3% |
| 47 | Newgenivf Group Limited | 1,234 | 12.3% |
| 48 | Imac Holdings Inc | 0 | - |
Market cap, return, momentum, beta and Sharpe ratio for the rest of Imac Holdings Inc's same-size peers requires a Commercial License.
Source: CSIMarket API (daily market-structure computation); returns and risk metrics as of 2026-09-29. Beta and Sharpe ratio are versus the broad U.S. equity market, not this industry.
Imac Holdings Inc's Valuation vs Competitive Position
Valuation multiples vs the Healthcare Facilities industry average (77 companies, excluding loss-making/negative-equity outliers), alongside returns on capital for context on whether a premium or discount lines up with measurably stronger or weaker returns. See the full Healthcare Facilities industry valuation benchmarks.| Metric | Company | Industry Average | Difference |
|---|---|---|---|
| P/E | - | 23.5x | - |
| EV / EBITDA | - | 15.7x | - |
| P/B | 0.0x | 3.3x | -3.3x |
| Return on Equity | 135.21 % | industry aggregate | 97.41 % |
| Return on Invested Capital | 46.59 % | 4.91 % (avg) | 41.68 % |
Source: CSIMarket API, trailing 12 months. A valuation premium or discount is not, by itself, a judgment of over- or under-valuation. Compare it against the return and growth context shown elsewhere on this page.
Imac Holdings Inc's Multi-Year Financial Trajectory
Fiscal-year revenue growth, operating margin, return on invested capital and P/E, as reported in SEC filings.| Metric | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Revenue Growth | - | -15.14 % | 12.08 % | 12.51 % | -500.00 % | - |
| Operating Margin | -40.89 % | -50.43 % | -70.20 % | -112.94 % | 0.13 % | - |
| Return on Invested Capital | -30.81 % | -35.97 % | -23.45 % | -70.41 % | -509.46 % | 76.37 % |
| P/E | - | - | - | - | - | - |
Source: CSIMarket API, fiscal-year figures. P/E is this company's own historical ratio at each fiscal year end and can swing sharply around an earnings trough: that is real, not a data error.
Imac Holdings Inc's BCG Growth-Share Matrix
Relative market share (vs Imac Holdings Inc's largest competitor by market cap) against industry revenue growth, using the standard textbook thresholds (1.0x share, 10% growth) a common framework, not a precision instrument.
Imac Holdings Inc falls in the Dog quadrant: relative market share of 0.00x vs its largest competitor, in an industry growing revenue 4.2% (median, trailing 12 months).
Source: CSIMarket API (market-cap share and industry revenue growth). The 10% growth and 1.0x share lines are standard textbook thresholds, not derived from this industry's own distribution. A caveat worth reading alongside this chart: Hca Healthcare Inc alone holds 39% of this industry's market cap. In an industry this dominated by one leader, the framework will place nearly every OTHER company in "Dog" or "Question Mark" purely because relative share is measured against that leader, regardless of how strong those other companies actually are on their own fundamentals. Check the Profitability, Valuation and Financial Strength sections above before treating this quadrant label as a verdict.
Imac Holdings Inc's Competitive Forces (Porter's Five Forces)
Only the forces this data can support honestly are shown; the other three are marked as such rather than guessed.| Force | Assessment | Basis |
|---|---|---|
| Competitive Rivalry | Moderate | Industry HHI of 1,726 (see Industry Market Structure & Concentration above) |
| Supplier Power | Not covered on this page | See Imac Holdings Inc's dedicated suppliers page for concentration and dependency data |
| Buyer Power | Not covered on this page | See Imac Holdings Inc's dedicated customers page for concentration and dependency data |
| Threat of Substitutes | - | No systematic data source for cross-product substitution exists in this system; not estimated |
Note: this is a partial, data-grounded application of the framework, not a complete strategic assessment. Rivalry and barriers-to-entry readings are mechanical translations of the HHI and capital-intensity figures shown elsewhere on this page, not independent judgments.
Imac Holdings Inc's Industry Attractiveness & Competitive Strength
A CSIMarket composite, not a standard field: each axis is an equal-weighted average of three factors already shown elsewhere on this page (industry growth, industry profitability and rivalry for attractiveness; relative market share, profitability and growth vs industry for strength). Disclosed as a designed methodology, not a precision measurement.
Imac Holdings Inc falls in the Low attractiveness / Low strength cell: Harvest / Divest.
Source: CSIMarket API, trailing 12 months. Each axis score is a simple 1(low)/2(medium)/3(high) average across its three inputs -- a transparent, disclosed simplification, not a validated academic scoring model.
Imac Holdings Inc's SWOT
Every point below is a fixed rule applied to a metric already shown elsewhere on this page (Market Structure, Profitability, Valuation, Run-Rate, Stock Performance, Quality Breadth) not an independent strategic assessment. A blank quadrant means no rule was met, not that none apply.Strengths
- Return on equity 97.4 points above the industry aggregate.
Weaknesses
- Latest-quarter revenue run-rate is decelerating (-99.4% annualized vs trailing 12 months).
- Low relative market share vs the industry leader (0.00x).
- Piotroski F-Score of 2 or below, the standard financial-distress signal.
Opportunities
No rule matched.
Threats
- Industry dominated by Hca Healthcare Inc , holding 38.51 % of industry market cap.
Methodology: mechanical, rule-based SWOT. Each bullet reuses a figure already sourced and cited elsewhere on this page; nothing here is generated narrative or independent analyst judgment.
Imac Holdings Inc's Financial Strength vs Peers Comparison
Quick ratio, working capital, debt to equity and asset turnover, trailing 12 months| Company | Quick Ratio | Working Capital | Debt / Equity |
|---|---|---|---|
| Imac Holdings Inc | 0.02 | 0.04 | - |
| Hca Healthcare Inc | 0.06 | 0.90 | - |
| Tenet Healthcare Corp | 0.53 | 1.54 | 3.16 |
| Fresenius Medical Care Ag | 0.26 | 1.26 | 0.40 |
| Encompass Health Corporation | 0.10 | 1.15 | 0.98 |
| Universal Health Services Inc | 0.04 | 1.07 | 0.72 |
Sign in to see all peers for Imac Holdings Inc .
Quick ratio = cash / current liabilities; working capital ratio = current assets / current liabilities; asset turnover = revenue / total assets. Peers in the Blank Checks industry are excluded.
Imac Holdings Inc's Revenue and Income Growth vs Peers
Quarterly revenue and net income growth, year over year and quarter over quarter| Company | Period | Revenue Y/Y | Income Y/Y |
|---|---|---|---|
| Imac Holdings Inc | Q3 2025 | -62.3 % | - |
| Hca Healthcare Inc | Q1 2026 | +4.3 % | +1.8 % |
| Tenet Healthcare Corp | Q2 2026 | +6.8 % | +100.2 % |
| Fresenius Medical Care Ag | Q4 2025 | +1.5 % | +60.8 % |
| Encompass Health Corporation | Q2 2026 | +9.6 % | +12.2 % |
| Universal Health Services Inc | Q2 2026 | +8.3 % | +0.5 % |
| PEERS TOTAL | +3.4 % | +21.7 % |
Sign in to see all peers for Imac Holdings Inc .
Growth is shown only where both periods are positive. Peers in the Blank Checks industry are excluded.
Imac Holdings Inc's Peers' Costs of Sales and Capital Expenditures
Context for revenue growth: peer costs and capex, year over year and quarter over quarter| Company | Period | Costs Y/Y | Capex Y/Y |
|---|---|---|---|
| Imac Holdings Inc | Q3 2025 | +1.5 % | - |
| Hca Healthcare Inc | Q1 2026 | - | +12.9 % |
| Tenet Healthcare Corp | Q2 2026 | +14.4 % | -13.0 % |
| Fresenius Medical Care Ag | Q4 2025 | +0.1 % | - |
| Encompass Health Corporation | Q2 2026 | - | +40.4 % |
| Universal Health Services Inc | Q2 2026 | - | -14.4 % |
Sign in to see all peers for Imac Holdings Inc .
Imac Holdings Inc's Returns and Turnover vs Peers
ROA, ROI and ROE (trailing 12 months), receivables and inventory turnover| Company | ROA | ROI | ROE |
|---|---|---|---|
| Imac Holdings Inc | - | - | - |
| Hca Healthcare Inc | 12.94% | 18.54% | - |
| Tenet Healthcare Corp | 10.49% | 9.98% | 50.64% |
| Fresenius Medical Care Ag | 3.84% | 4.81% | 8.34% |
| Encompass Health Corporation | 11.60% | 11.56% | 25.52% |
| Universal Health Services Inc | 9.92% | 12.43% | 20.89% |
Sign in to see all peers for Imac Holdings Inc .
ROA = net income / total assets; ROI = net income / investments; ROE = net income / equity; turnover ratios use trailing 12 month revenue (receivables) and cost of sales (inventory).
Imac Holdings Inc's Valuation vs Peers
P/E, price to sales, PEG, price to cash flow and price to book| Company | P/E | Price / Sales |
|---|---|---|
| Imac Holdings Inc | - | 0.00 |
| Hca Healthcare Inc | 14.96 | 1.28 |
| Tenet Healthcare Corp | 7.10 | 0.99 |
| Fresenius Medical Care Ag | 11.75 | 0.59 |
| Encompass Health Corporation | 19.99 | 1.98 |
| Universal Health Services Inc | 7.23 | 0.58 |
| PEERS AVERAGE | 11.68 | 0.98 |
Sign in to see all peers for Imac Holdings Inc .
P/E = price / diluted EPS (trailing 12 months); PEG = P/E divided by EPS growth; the average row divides the peers' combined market cap by their combined income, sales, cash flow and equity.